investigating ros1 and trk rearrangements in lung cancer
Published 5 years ago • 155 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
1:05
investigating resistance in ros1 lung cancer
-
18:41
extreme rare mutations in lung cancer (ros1, trk, her2): treatment opportunities
-
1:55
multiple therapies show responses in lung cancer with ros1 fusions
-
5:30
sequencing therapy in alk/ros1-rearranged nsclc
-
1:27
targeted therapies show activity in ros1 fusion-positive lung cancer
-
1:36
dr. drilon on targeted therapies for patients with ros1-rearranged lung cancer
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
4:55
ros1-rearranged nsclc
-
3:15
ros1 rearrangements in mnsclc
-
40:53
alk and ros1 in lung cancer next generation targeted therapies
-
40:53
alk and ros1 in lung cancer next generation targeted therapies
-
1:53
ros-1 rearrangements: what are they?
-
40:53
alk and ros1 in lung cancer next generation targeted therapies
-
2:29
dr. ross camidge discusses crizotinib in ros1 rearranged nsclc
-
1:33
what is an alk rearrangement in lung cancer?
-
4:49
emerging alk/ros1 tkis for nsclc
-
9:33
second-line brigatinib for alk/ros1-rearranged nsclc
-
21:08
pathologic testing for alk and ros1 aberrations in nsclc | frédérique penault-llorca
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer